Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management
Sponsor: Ankara Ataturk Sanatorium Training and Research Hospital
Summary
In this randonmized controlled trial, aim to compare the effectiveness of local administration of tranexamic acid and blood stopper (Ankaferd®) on cessation of bleeding in epistaxis patients.
Official title: Comparison of the Efficacy of Tranexamic Acid and Blood Stopper Treatments in Bleeding Control in Patients With Epistaxis: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
186
Start Date
2024-10
Completion Date
2025-12
Last Updated
2024-07-08
Healthy Volunteers
No
Conditions
Interventions
Blood Stopper (Ankaferd)
5 ml of Ankaferd® will be sprayed through the bleeding side nostril and external nasal pressure will be performed for 10 minutes.